Duration of antibody responses after severe acute respiratory syndrome
- PMID: 18258008
- PMCID: PMC2851497
- DOI: 10.3201/eid1310.070576
Duration of antibody responses after severe acute respiratory syndrome
Abstract
Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >or=3 years after initial exposure.
Figures


Similar articles
-
Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome.J Infect Dis. 2006 Mar 15;193(6):792-5. doi: 10.1086/500469. Epub 2006 Feb 9. J Infect Dis. 2006. PMID: 16479513 Free PMC article.
-
Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients.Clin Diagn Lab Immunol. 2005 Dec;12(12):1455-7. doi: 10.1128/CDLI.12.12.1455-1457.2005. Clin Diagn Lab Immunol. 2005. PMID: 16339072 Free PMC article.
-
Disappearance of antibodies to SARS-associated coronavirus after recovery.N Engl J Med. 2007 Sep 13;357(11):1162-3. doi: 10.1056/NEJMc070348. N Engl J Med. 2007. PMID: 17855683 No abstract available.
-
SARS Immunity and Vaccination.Cell Mol Immunol. 2004 Jun;1(3):193-8. Cell Mol Immunol. 2004. PMID: 16219167 Review.
-
Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals.Ann N Y Acad Sci. 2006 May;1067(1):500-5. doi: 10.1196/annals.1354.072. Ann N Y Acad Sci. 2006. PMID: 16804033 Free PMC article. Review.
Cited by
-
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.Front Immunol. 2020 Aug 11;11:1991. doi: 10.3389/fimmu.2020.01991. eCollection 2020. Front Immunol. 2020. PMID: 32903476 Free PMC article. Review.
-
Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery.J Thorac Cardiovasc Surg. 2020 Aug;160(2):447-451. doi: 10.1016/j.jtcvs.2020.04.059. Epub 2020 Apr 27. J Thorac Cardiovasc Surg. 2020. PMID: 32689700 Free PMC article.
-
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response.Life (Basel). 2023 Oct 26;13(11):2121. doi: 10.3390/life13112121. Life (Basel). 2023. PMID: 38004261 Free PMC article. Review.
-
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.Lancet. 2020 Nov 14;396(10262):1595-1606. doi: 10.1016/S0140-6736(20)32137-1. Epub 2020 Oct 13. Lancet. 2020. PMID: 33065034 Free PMC article. Review.
-
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.J Clin Med. 2021 Feb 16;10(4):779. doi: 10.3390/jcm10040779. J Clin Med. 2021. PMID: 33669185 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous